DEVELOPMENT OF A MODEL TO PREDICT DISEASE PROGRESSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

被引：0

作者：

McEwan, P. ^{[1
]}

Wilton, Bennett H. ^{[2
]}

Robinson, P. ^{[3
]}

Hadimeri, H. ^{[4
]}

Ong, A. ^{[5
]}

Orskov, B. ^{[6
]}

Peces, R. ^{[7
]}

Sandford, R. ^{[8
]}

Scolari, F. ^{[9
]}

Walz, G. ^{[10
]}

Woon, C. ^{[11
]}

O'Reilly, K. ^{[3
]}

机构：

[1] Swansea Ctr Hlth Econ, Swansea, W Glam, Wales

[2] Hlth Econ & Outcomes Res Ltd, Cardiff, Wales

[3] Otsuka Pharmaceut Europe Ltd, Wexham, Bucks, England

[4] Karnsjukhuset, Dept Nephrol, Skovde, Sweden

[5] Univ Sheffield, Sch Med, Dept Infect & Immun, Acad Nephrol Unit, Sheffield S10 2TN, S Yorkshire, England

[6] Copenhagen Univ Hosp, Div Renal, Dept Med, Roskilde, Denmark

[7] Hosp Univ La Paz, Madrid, Spain

[8] Addenbrookes Treatment Ctr, Acad Lab Med Genet, Cambridge, England

[9] Univ Brescia, Dept Nephrol, I-25121 Brescia, Italy

[10] Zentrale Klin Forsch, Univ Med Ctr Freiburg, Dept Nephrol, Freiburg, Germany

[11] McCann Complete Med, Macclesfield, Cheshire, England

来源：

VALUE IN HEALTH | 2014年 / 17卷 / 07期

关键词：

D O I：

10.1016/j.jval.2014.08.1870

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PRM118

引用

页码：A564 / A564

页数：1

共 50 条

[21] PARAMETERS ASSOCIATED WITH PROGRESSION, PROGNOSIS AND TOLVAPTAN INDICATION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
Gkika, Vasiliki
Louka, Michaela
Fokas, Stavros
Tigka, Eirini
Drakopoulos, Angelos
Markou, Niki
Doumani, Georgia
Kostopoulou, Myrto
Tsagkatakis, Mihail
Tsirpanlis, George
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I5 - I5
[22] PREDICTORS OF DISEASE PROGRESSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Andronesi, Andreea
Petrescu, Camelia
Fetecau, Andreea
Jurubita, Roxana
Andronesi, Danut
Ismail, Gener
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 95 - 96
[23] Parameters Associated With Progression, Prognosis, and Tolvaptan Indication in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Gkika, Vasiliki
Louka, Michaela
Tigka, Eirini
Drakopoulos, Angelos
Kostopoulou, Myrto
Tsirpanlis, George I.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 155 - 155
[24] Renal disease progression in autosomal dominant polycystic kidney disease
Eiji Higashihara
Shigeo Horie
Satoru Muto
Toshio Mochizuki
Saori Nishio
Kikuo Nutahara
Clinical and Experimental Nephrology, 2012, 16 : 622 - 628
[25] Glis3 Is a Modifier of Cyst Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Wei, Zemeng
Tian, Xin
Rehman, Michael
Dong, Ke
Cai, Yiqiang
Cordido, Adrian
Somlo, Stefan
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
[26] Kidney volume enlargement in unilateral autosomal dominant polycystic kidney disease (ADPKD)
Poster, D.
Krauer, F.
Kistler, A.
Weishaupt, D.
Wuethrich, R. P.
Serra, A.
SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 11S - 11S
[27] Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD
Dana Rizk
Arlene Chapman
Pediatric Nephrology, 2008, 23 : 1029 - 1036
[28] USING ELECTRONIC HEALTH RECORDS TO EVALUATE DOCUMENTATION OF DISEASE PROGRESSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
Halpern, Rachel
Sanon, Myrlene
Korrer, Stephanie
Anderson, Amy
Pareja, Kristin
Nourbakshsh, Ali
Seare, Jerry
AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 578 - 579
[29] Intracranial arterial dolichoectasia in autosomal dominant polycystic kidney Disease (ADPKD).
Schievink, WI
Torres, VE
Wiebers, DO
Huston, J
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1868 - A1868
[30] Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD
Rizk, Dana
Chapman, Arlene
PEDIATRIC NEPHROLOGY, 2008, 23 (07) : 1029 - 1036

← 1 2 3 4 5 →